The development comes after DCGI (Drugs Controller General of India) gave its nod to foreign-made and approved COVID-19 vaccines following a massive spike in coronavirus cases

India will provide approvals to COVID-19 vaccines approved by health regulators like US FDA within 3 days; detailled guidelines to come soon

We have determined to voluntarily suspend our rollout until the causal relationship between the development of clots and the Johnson and Johnson vaccine is sufficiently interrogated, Health Minister Zweli Mkhize said in a statement

The Johnson & Johnson pause, which regulators say they hope to resolve within days, comes on the heels of production issues at the Baltimore plant that produces the J&J vaccine

The Centers for Disease Control and Prevention and the Food and Drug Administration, in a joint statement on Tuesday, said it was probing clots in six women in the days after vaccination, in combination with reduced platelet counts

The teens will be added to an ongoing study of the vaccine in adults that began last September, the New Brunswick, New Jersey-based drugmaker said Friday

The US Food and Drug Administration (FDA) cleared Moderna to speed up vaccine output by letting it fill a single vial with up to 15 doses

Dr Hans Kluge, WHO's regional director for Europe, said vaccines present our best way out of this pandemic, but noted that to date, only 10% of Europe's population has received one dose and that only 4% have been fully protected with two doses

The vaccine was also effective in South Africa, where B.1.351 lineage of the virus is prevalent. It said nine cases of COVID-19 were observed in the country, all in the placebo group.

A vaccine ingredient made by Emergent BioSolutions -- one of about 10 companies that Johnson and Johnson is using to speed up manufacturing of its recently approved vaccine -- did not meet quality standards, J&J said on Wednesday

India close to becoming 2nd largest COVID-19 infected nationIndia is closing in on Brazil to become the second country after the US in terms of total number of COVID-19 cases in the world. Total number of cases in India has reached 12,148,487 cases as of yesterday, whereas Brazil is still ahead with 12,664,058 cases. While Brazil had 86,704 new cases, that in India was 53,158. While Brazil has a population of only 21.36 crore, that in India is 139 crore.New COVID-19 wave hits hospitality se...

The companies plan to submit the data from the trial to U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of the vaccine.

The Board of Directors of GlaxoSmithKline Pharmaceuticals approved the sale of the manufacturing facility

This move to further revise the prices will go a long way in helping patients during these critical times, the company said.

Stock Market News Update Today: The BSE Sensex witnessed broader-based selling with 28 out of 30 BSE index heavyweights ending in red amid fear that second and third wave infections in India are bound to hamper economic recovery

Stock Market News Update Today: UltraTech Cement, Titan Company, ICICI Bank, IndusInd Bank, Axis Bank were among top gainers, while ONGC, Power Grid Corporation of India, ITC, NTPC, HDFC were among top losers

The early findings from the US study are just one set of information AstraZeneca must submit to the Food and Drug Administration

The Pennsylvania-based biopharmaceutical firm is partnering with India's Bharat Biotech, a developer of the vaccine, to commercialize the shot in the United States

Providing a final clearance for the vaccine a day after it was authorized by U.S. regulators, the Advisory Committee on Immunization Practices (ACIP) voted 12-0 to recommend the vaccine from J&J as appropriate for Americans 18 and older

The FDA said J&J's vaccine offers strong protection against what matters most: serious illness, hospitalisations, and death